News CEO Meek looks to boost Ipsen with drug acquisitions Could French biotech snap up remaining rights to pancreatic cancer drug?
News FDA approves first ALS treatment for two decades FDA asked Mitsubishi to file Radicava following approval in Japan.
News Biotech IPO market heats up as BioHaven's debut impresses BioHaven raises $168 million with biggest biotech IPO seen this year.
Views & Analysis Ultra-rare disease drugs: has access in England just got har... Gaining access to ultra-orphan drugs could become much more difficult.
Views & Analysis Getting a rarer perspective Benefitting from insights from focus groups with rare disease patients.
News Biogen shares up after strong launch for rare disease drug US insurers are covering the treatment, despite high price.
News UK's Mission divests kidney drug to Dimerix for $292m Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
